Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein

被引:78
|
作者
Rothenburger, M
Markewitz, A
Lenz, T
Kaulbach, HG
Marohl, K
Kuhlmann, WD
Weinhold, C
机构
[1] Cent Mil Hosp, Dept Cardiovasc Surg, Koblenz, Germany
[2] Cent Mil Hosp, Dept Anesthesiol, Koblenz, Germany
[3] Cent Lab Inst, Koblenz, Germany
关键词
procalcitonin; C-reactive protein; cardiac surgery; major surgical trauma; cardiopulmonary bypass infection; acute phase response;
D O I
10.1515/CCLM.1999.048
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: Established parameters, e.g. C-reactive protein (CRP), do not differentiate specifically enough between patients developing an infection and those exhibiting an acute phase response following cardiac surgery. The objective of this prospective study was to investigate if procalcitonin (PCT) ist more helpful than CRP. Methods: During a 1-year period, seven out of 563 patients (1.2 %) developed systemic infections (group A) after cardiac operations with cardiopulmonary bypass (CPB), and additional eight patients (1.4%) had local wound infections requiring surgical therapy (group B). Blood samples for PCT and CRP measurements were taken preoperatively, at the onset of infection (d1), as well as on the third day (d3), fifth day (d5), and seventh day (d7) following diagnosis of infection. Forty-four randomly selected patients undergoing cardiac surgery with CPB without clinical signs of infection, additional intensive care unit (ICU) management or additional antibiotic treatment served as control (group C) to assess the PCT and CRP contribution to acute phase response. PCT and CRP levels were measured preoperatively, on the first (dl), third (d3) and fifth day (d5) after operation. Results: At the onset of infection, PCT levels (median interquartile range 25%-75%) increased significantly in group A as compared to baseline values (10.86 (3.28-15.13) ng/ml vs. 0.12 (0.08-0.21) ng/ml), and decreased during treatment to still significantly elevated values on d5 (0.56 (0.51-0.85)ng/ml). CRP levels were significantly elevated on all days investigated with no trend towards normalisation (dl: 164.5 (137-223) mg/l) vs. 1.95 (1.1-2.8) mg/l preoperatively, d5: 181.1 (134-189.6) mg/l. In group B, no increase in PCT levels, but a significant increase of CRP from dl (165.9 (96.6-181.6) mg/l vs. 3.7 (2-4.3) mg/l preopratively) until d5 98 (92.8-226.2) mg/l was detected. In group C, postoperative PCT levels increased slightly but significantly in the absence of infection on dl (0.46 (0.26-0.77) ng/ml vs. 0.13 (0.08-0.19) ng/ml preoperatively, and d3 (0.37 (0.2-0.65)ng/ml and reached baseline on d5 (0.24 (0.11-0.51) ng/ml)). CRP levels were significantly elevated as compared to baseline on all postoperative days investigated (baseline: 1.75 (0.6-2.9) mg/l, dl: 97.5 (74.5-120) mg/l), d3: 114(83.05-168.5) mg/l, d5: 51.4 (27.4-99.8) mg/l)). PCT showed a significant correlation to CRP in group A (r = 0.48, p<0.001), a weak correlation in group C (r = 0.27, p = 0.002) and no correlation in group B. Intergroup comparison revealed a significant difference for PCT between all groups (A>C>B) and significantly higher CRP levels in group A vs. C and in group B vs. C. Thus, the pattern high PCT/high CRP appears to indicate a systemic infection, while low PCT/high CRP indicates either acute phase response or local wound problems but no systemic infection. The cost for PCT measurements was 5.6-fold higher as compared to CRP. Conclusion: Due to the significant differences in the degree of increase, PCT appears to be useful in discriminating between acute phase response following cardiac surgery with CPB or local problems and systemic infections, with additional CRP-measurement increasing the specifity.
引用
收藏
页码:275 / 279
页数:5
相关论文
共 50 条
  • [21] Contested role of procalcitonin and C-reactive protein in the diagnosis of fascioliasis
    Cakir, Fatih
    Bilden, Alican
    Ozcan, Nida
    Cicek, Mutalip
    PARASITOLOGISTS UNITED JOURNAL, 2022, 15 (01) : 117 - 120
  • [22] Procalcitonin or C-Reactive Protein: That Is the Question?
    Corona, Alberto
    De Iaco, Mose
    CRITICAL CARE MEDICINE, 2014, 42 (04) : E310 - E311
  • [23] Procalcitonin and C-Reactive Protein/Procalcitonin Ratio as Markers of Infection in Patients With Solid Tumors
    Vassallo, Matteo
    Michelangeli, Celine
    Fabre, Roxane
    Manni, Sabrina
    Genillier, Pierre L.
    Weiss, Nicolas
    Blanchouin, Elea
    Saudes, Laurence
    Kaphan, Regis
    Puchois, Annick
    Pradier, Christian
    Montagne, Nathalie
    FRONTIERS IN MEDICINE, 2021, 8
  • [24] C-Reactive Protein and Procalcitonin Are Predictors of the Severity of Acute Appendicitis in Children
    Gavela, Teresa
    Cabeza, Beatriz
    Serrano, Ana
    Casado-Flores, Juan
    PEDIATRIC EMERGENCY CARE, 2012, 28 (05) : 416 - 419
  • [25] Usefulness of procalcitonin and C-reactive protein in the acute meningitis in the emergency department
    Julian-Jimenez, A.
    Flores Chacartegui, M.
    Palomo de Los Reyes, M. J.
    Brea-Zubigaray, S.
    NEUROLOGIA, 2013, 28 (03): : 189 - 190
  • [26] The Role of Procalcitonin and C-Reactive Protein in Prediction of Etiology of Bloodstream Infections
    Alici, Ayse
    Cetin, Sirin
    Cetin, Meryem
    Dortok, Hatice
    KLIMIK JOURNAL, 2023, 36 (04) : 268 - 273
  • [27] Procalcitonin or C-Reactive Protein: That Is the Question? Reply
    Nobre, Vandack
    Oliveira, Carolina Ferreira
    Alves Oliveira, Clara Rodrigues
    CRITICAL CARE MEDICINE, 2014, 42 (04) : E311 - E312
  • [28] THE ROLE OF PROSTAGLANDINS IN THE C-REACTIVE PROTEIN RESPONSE
    SCHULTZ, D
    MACINTYRE, S
    CHELLADURAI, M
    KUSHNER, I
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 389 (JUN) : 465 - 466
  • [29] Role of markers C-Reactive Protein, Procalcitonin and TREM-1 in diagnosis of infection pleural effusion
    Alvarenga, Vanessa
    Acencio, Milena
    Sales, Roberta
    Silva, Aline
    Silva, Jucara
    Silva, Carlos
    Teixeira, Lisete Ribeiro
    Marchi, Evaldo
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [30] Role of procalcitonin and C-reactive protein for discrimination between tumor fever and infection in patients with hematological diseases
    Hangai, Sho
    Nannya, Yasuhito
    Kurokawa, Mineo
    LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 910 - 914